• Mon, August 31, 2015
  • Tue, September 1, 2015
  • Wed, September 2, 2015
  • Thu, September 3, 2015
  • Mon, September 7, 2015
  • Tue, September 8, 2015
  • Fri, September 4, 2015

Paul Matteis Maintained (ALNY) at Buy with Increased Target to $151 on, Aug 31st, 2015

Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $145 to $151 on, Aug 31st, 2015.

Paul has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015


These are the ratings of the 2 analyists that currently disagree with Paul


  • Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $180 on, Monday, June 15th, 2015

Like: 👍